Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127914111 | 12791411 | 1 | I | 20140603 | 20160929 | 20160929 | EXP | PHHY2014CA068702 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160929 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127914111 | 12791411 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 450 MG, QD | 22068 | 450 | MG | CAPSULE | QD | ||||||
| 127914111 | 12791411 | 2 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127914111 | 12791411 | 1 | Chronic myeloid leukaemia |
| 127914111 | 12791411 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127914111 | 12791411 | Acne | |
| 127914111 | 12791411 | Alopecia | |
| 127914111 | 12791411 | Arthralgia | |
| 127914111 | 12791411 | Hair colour changes | |
| 127914111 | 12791411 | Pain | |
| 127914111 | 12791411 | Pruritus | |
| 127914111 | 12791411 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127914111 | 12791411 | 1 | 20131201 | 0 |